Invivyd (IVVD) Change in Account Payables (2021 - 2025)
Invivyd posted quarterly Change in Account Payables of -$4.2 million for Q4 2025, up 41.76% year-on-year from -$3.0 million in Q4 2024, and down 1847.71% on a QoQ basis from -$218000.0 in Q3 2025.
Invivyd (IVVD) has 5 years of Change in Account Payables data on file, last reported at -$4.2 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Account Payables rose 41.76% year-over-year to -$4.2 million; the trailing twelve-month figure through Dec 2025 stood at $3.2 million (up 32.52% YoY), and the FY2025 full-year result was $3.2 million, up 32.52% from the prior year.
- Change in Account Payables for Q4 2025 stood at -$4.2 million, down from -$218000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $12.9 million in Q1 2022 and bottomed at -$14.7 million in Q4 2022.
- The 5-year median for Change in Account Payables is -$611500.0 (2021), against an average of $271750.0.
- Peak annual rise in Change in Account Payables reached 443.75% in 2024, while the deepest fall reached 500.58% in 2024.
- A 5-year view of Change in Account Payables shows it stood at -$11.3 million in 2021, then slumped by 30.07% to -$14.7 million in 2022, then surged by 91.73% to -$1.2 million in 2023, then plunged by 500.58% to -$7.3 million in 2024, then soared by 41.76% to -$4.2 million in 2025.
- The last three Change in Account Payables figures came in at -$4.2 million (Q4 2025), -$218000.0 (Q3 2025), and $9.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Invivyd | 208.38 Mn | -18.31 Mn | - | -4.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.25 Mn |
| Dec 31, 2025 | -4.25 Mn |
| Sep 30, 2025 | -218,000.00 |
| Sep 30, 2025 | -218,000.00 |
| Jun 30, 2025 | 9.31 Mn |
| Jun 30, 2025 | 9.31 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Dec 31, 2024 | -7.29 Mn |
| Dec 31, 2024 | -7.29 Mn |
| Sep 30, 2024 | 10.31 Mn |
| Sep 30, 2024 | 10.31 Mn |
| Jun 30, 2024 | 6.19 Mn |
| Jun 30, 2024 | 6.19 Mn |
| Mar 31, 2024 | -6.79 Mn |
| Mar 31, 2024 | -6.79 Mn |
| Dec 31, 2023 | -1.21 Mn |
| Dec 31, 2023 | -1.21 Mn |
| Sep 30, 2023 | 5.06 Mn |
| Sep 30, 2023 | 5.06 Mn |
| Jun 30, 2023 | -1.80 Mn |
| Jun 30, 2023 | -1.80 Mn |
| Mar 31, 2023 | 4.43 Mn |
| Mar 31, 2023 | 4.43 Mn |
| Dec 31, 2022 | -14.67 Mn |
| Dec 31, 2022 | -14.67 Mn |
| Sep 30, 2022 | 1.92 Mn |
| Sep 30, 2022 | 1.92 Mn |
| Jun 30, 2022 | -4.45 Mn |
| Jun 30, 2022 | -4.45 Mn |
| Mar 31, 2022 | 12.90 Mn |
| Mar 31, 2022 | 12.90 Mn |
| Dec 31, 2021 | -11.28 Mn |
| Dec 31, 2021 | -11.28 Mn |
| Sep 30, 2021 | 6.75 Mn |
| Sep 30, 2021 | 6.75 Mn |
| Jun 30, 2021 | -1.01 Mn |
| Jun 30, 2021 | -1.01 Mn |
| Mar 31, 2021 | 3.16 Mn |
| Mar 31, 2021 | 3.16 Mn |